Morning Headlines 7/6/15

Theranos receives FDA clearance and review and validation of revolutionary finger stick technology, test, and associated test system

Palo Alto-based lab test vendor Theranos announces that it has secured FDA clearance for its testing process, which it says is cheaper, faster, and requires a smaller sample than traditional lab tests.

Aetna Agrees to Buy Humana for $34.1 Billion

Aetna will acquire Humana for $34.1 billion, or $230 a share, a 23 percent premium over Humana’s closing stock price on Thursday.

In Health Law, a Boon for Diet Clinics

The New York Times analyzes a component of the ACA that requires insurers to cover nutrition and obesity screenings and the effect the requirement is having on the for-profit weight loss industry.

Deadline confusion threatens EPAS rollout to new hospital

In Australia, the Royal Adelaide Hospital, a new 800-bed facility being constructed in South Australia, may fail to bring its Allscripts EHR implementation live prior to its scheduled 2016 opening because it mixed up its own go-live deadlines and has been struggling with clinical adoption issues.